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The ribosome is the target of a large number of antibiotics. Here, we report a 3.4-Å-resolution crystal structure of
bactobolin A bound to 70S ribosome–tRNA complex. The antibiotic binds at a previously unseen site in the 50S
subunit and displaces tRNA bound at the P-site. It thus likely has a similar mechanism of action as blasticidin S
despite binding to a different site. The structure also rationalizes previously identified resistance mutations.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Structural studies have been instrumental in reveal-
ing the molecular basis of the action of antibiotics [1].
Those studies showed that many antibiotics inhibit
various steps of the elongation cycle of translation [2],
whereas relatively few clinically useful compounds
target initiation [3]. Recently, it was suggested that
blasticidin S (BlaS) acts by inhibiting termination [4].
Bactobolin is a member of the polyketide-peptide
family of molecules produced by Burkholderia
thailandensis [5]. These water-soluble compounds
consist of a C6-polyketide fused to a chlorinated
hydroxy-valine residue (Fig. 1a). Recently, it was
shown to inhibit protein synthesis, and resistance to
bactobolin is acquired by mutations in the 50S
ribosomal protein uL2 [6]. Bactobolin-resistant mu-
tants remain susceptible to other known ribosome
inhibitors, suggesting that it binds to a novel target
site in the ribosome.
To help understand themolecular basis of its action,
we determined the crystal structure of bactobolin A
bound to the Thermus thermophilus 70S ribosome in
the presence of mRNA and tRNA. The resolution of
3.4 Å allowed us to visualize the antibiotic and deduce
its interactions with the ribosome and tRNA. Following
refinement of the initial model, we placed bactobolin A
in the electron density (Fig. 1b and c). The antibiotic is
coordinated primary by helix 73, and its interactions
with the ribosome involve a Mg2+ ion that allows it to
interact with A2613 through both of its rings via theAuthors. Published by Elsevier Ltd. This
rg/licenses/by-nc-nd/4.0/).carbonyl oxygen of the lactone and the hydroxyl of the
enol (Fig. 1c). The additional enol hydroxyl is boundby
C2085, whereas the chlorides of the lactone ring are
coordinated by U2449, A2611 and C2612. The
binding of bactobolin is further stabilized by the
amine termini of hydroxy-valine interacting with
A2450. This holds bactobolin in the orientation that
results in direct contacts with the CCA end of P-site
tRNA (Fig. 1c and d).
A superposition of our structure with a 70S–tRNA
complex without the antibiotic shows that bactobolin
would clash sterically with canonical P-site tRNA
(Fig. 1d). Thus, in order to accommodate both tRNA
and the antibiotic, the CCA backbone of P-site tRNA is
displaced in our structure (Fig. 1d). Consequently, A76
of P-tRNA no longer contacts C2063 and is shifted
3.6 Å toward the A-site. Such a conformational change
of the P-site tRNA caused by bactobolin A suggests
that it would inhibit peptidyl transfer. However, the
structural effect of bactobolin A binding is similar to the
one recently reported for BlaS [4]. It has been further
shown that BlaS-stimulated distortion of CCA P-tRNA
would occlude the access of a release factor to the
A-site and thus inhibit translation termination, which is
also supported by biochemical data [4]. The fact
that BlaS and bactobolin A have overlapping binding
sites (Fig. 1b) and cause a similar conformational
rearrangement of P-site tRNAsuggests that bothact as
translation termination inhibitors.
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Fig. 1. Binding of bactobolin A to the ribosome in the presence of P-tRNA. (a) Chemical structure of bactobolin.
(b) Relative positions of bactobolin, tRNA and uL2; overlapping of bactobolin and BlaS binding sites. (c) Unbiased Fo − Fc
difference map corresponding to bactobolin A and adjacent Mg2+ ion (yellow sphere) is contoured at 3σ. rRNA forming
contacts with bactobolin is shown. E236 of uL2 stabilizes A2450. (d) Superposition of tRNA in the 70S-tRNA-bactobolin
complex with that from antibiotic-free 70S-tRNA, demonstrating the shift of the CCA end toward the A-site.
754 Bactobolin A and 70S RibosomeThe crystal structure also rationalizes biochemical
data that identified a mutation in E236 (Bacillus
subtilis) of uL2 protein as a cause of resistance to
bactobolin [6]. The resistance can be explained by
disruption of E236:A2450 contacts (Fig. 1c). Since
A2450 is directly involved in coordinating bactobolin
A, the mutation is likely to disorder the binding site.
We note that the previously described bactobolin-
resistant mutants remain susceptible to BlaS.Acknowledgements
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